Sensei Biotherapeutics In...
(SNSE)
undefined
undefined%
At close: undefined
0.51
-2.28%
After-hours Jan 06, 2025, 07:52 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -34.10M | -48.59M | -36.79M | -20.10M | -16.74M | -13.04M |
| Depreciation & Amortization | 1.35M | 1.35M | 685.00K | 209.00K | 73.00K | 44.00K |
| Stock-Based Compensation | 4.45M | 5.81M | 5.66M | 1.49M | 1.18M | 1.19M |
| Other Working Capital | -2.00M | -1.01M | 1.54M | -732.00K | 1.13M | 559.00K |
| Other Non-Cash Items | 603.00K | 1.40M | 57.00K | 2.13M | 1.48M | 349.00K |
| Deferred Income Tax | n/a | n/a | 19.00K | -1.04M | 1.97M | n/a |
| Change in Working Capital | -4.33M | 1.01M | 117.00K | -397.00K | 3.47M | 1.49M |
| Operating Cash Flow | -32.02M | -39.03M | -30.26M | -17.70M | -8.57M | -10.31M |
| Capital Expenditures | -180.00K | -321.00K | -2.03M | -1.21M | -53.00K | -31.00K |
| Acquisitions | n/a | 15.00K | 318.00K | -197.00K | n/a | n/a |
| Purchase of Investments | -21.15M | -46.87M | -183.67M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 59.58M | 97.12M | 42.26M | n/a | n/a | n/a |
| Other Investing Acitivies | 166.00K | 50.27K | -141.09K | -197.00K | n/a | n/a |
| Investing Cash Flow | 38.41M | 49.95M | -143.12M | -1.40M | -53.00K | -31.00K |
| Debt Repayment | -761.00K | -629.00K | -255.00K | 526.00K | 8.07M | 750.00K |
| Common Stock Repurchased | -10.38M | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -28.00K | n/a | 23.60M | 34.93M | 154.00K | n/a |
| Financial Cash Flow | -11.17M | -287.00K | 163.94K | 35.45M | 8.22M | 750.00K |
| Net Cash Flow | -4.78M | 10.64M | -9.44M | 16.34M | -402.00K | -9.59M |
| Free Cash Flow | -32.20M | -39.35M | -32.28M | -18.91M | -8.62M | -10.34M |